Angiocrine Bioscience Funding: $15M Raised, Series B (2022)
Angiocrine Bioscience is based in San Diego, CA. It has raised $15M in total funding. Latest round: Series B.
Angiocrine Bioscience funding overview
Angiocrine Bioscience is based in San Diego, CA. Angiocrine Bioscience has raised $15M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in December 2022. The round record for Angiocrine Bioscience runs through 2022; nothing later has been disclosed. Investors on record include California Institute for Regenerative Medicine (CIRM).
Angiocrine Bioscience at a glance
Total raised
$15M
Latest round
Series B
Latest round date
December 2022
Headquarters
San Diego, CA
Notable investors
California Institute for Regenerative Medicine (CIRM)
Frequently asked about Angiocrine Bioscience funding
How much has Angiocrine Bioscience raised?
Angiocrine Bioscience has raised $15M in total disclosed funding across the rounds on record.
Who has invested in Angiocrine Bioscience?
California Institute for Regenerative Medicine (CIRM) are named among the investors backing Angiocrine Bioscience.
What was the latest Angiocrine Bioscience funding round?
The most recent disclosed round is a Series B, announced in December 2022.
Where is Angiocrine Bioscience based?
Angiocrine Bioscience is based in San Diego, CA.
When did Angiocrine Bioscience last raise?
The last disclosed Angiocrine Bioscience round closed in December 2022 at Series B.
Totals shown for Angiocrine Bioscience aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
